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The analysis of RNA extracted from purified Akabane virus demonstrated the
presence of three size classes of single-stranded RNAs with sedimentation
coefficients of 31S (large, L), 26S (medium, M), and 13S (small, S). Molecular
weights of these RNA species were estimated to be 2.15 x 106 ,1.5 X 106 , and 0.48
x 106 for the L, M, and S RNAs, respectively. Hybridization analysis involving
viral genomic RNA and RNA from virus-infected cells resulted in the identification of four virus-specific cRNA species in infected cells. These cRNAs were
found to be nonpolyadenylated by their inability to bind to oligodeoxythymidylate-cellulose. Kinetic analysis of cRNA synthesis in infected cells at various times
postinfection suggested that cRNA synthesis could be detected as early as 2 h
postinfection and that maximal synthesis occurred at 4 to 6 h postinfection. The
RNAs synthesized in infected cells could be partially resolved by sucrose density
gradient centrifugation. The RNA fraction that cosedimented with the S segment
of viral genomic RNA yielded two duplex RNA species when hybridized with
viral genomic RNA, suggesting the presence of two small cRNA species. Specific
hybridization with individual viral genomic RNAs confirmed that two species of
cRNA are coded by the S RNA segment. Analysis of cRNA synthesis in the
presence of the protein synthesis inhibitors cycloheximide and puromycin indicated that cycloheximide completely inhibited virus-specific RNA synthesis early
and late in infection, whereas a very low level of synthesis occurred in the
presence of puromycin. The inhibitory effects of these drugs were found to be
reversible when the drugs were washed from the cells. It is concluded that
continued protein synthesis is required for cRNA synthesis to proceed in Akabane
virus-infected cells.
Akabane virus is a member of the genus
Bunyavirus and family Bunyaviridae (7). All
bunyaviruses so far characterized contain three
unique segments of single-stranded RNA (large
[L], medium [M], and small [S]) of negative
polarity with a total molecular weight of approximately 4 x 106 to 6 X 106 (3). These RNAs
reside within the virion as three helical and
circular nucleocapsids, being complexed with
multiple copies of a nucleocapsid protein (N)
and a few copies of a large protein (L), believed
to be a transcriptase component (5). Two external glycoproteins (Gl and G2) form the spikes on
the viral envelope; Gl protein contains a site for
binding to cellular receptors and also functions
as the viral hemagglutinin, whereas the function
of G2 still remains to be demonstrated (15). A
recent report (25) also suggests the presence of a
fifth virion-associated polypeptide of molecular
weight 16,000 (16K). In addition to these structural proteins, the viral genome also codes for
several non structural proteins (12). Recombination studies (4, 13, 14) show that the small viral

RNA contains coding information for the N
protein, whereas the M RNA segment contains
the information for both G1 and G2. It is therefore inferred that the L protein is coded by the L
RNA segment.
Although more than five virus-specific proteins have been identified, the mechanism of
bunyavirus gene expression in infected cells
remains to be explained. It is not known how
many mRNAs mediate the expression of three
genome segments into more than five virusspecific polypeptides. Using duplex RNA analyses, Cash et al. (9) identified the presence of
three cRNA species in snowshoe hare virusinfected cells but could only detect messenger
activity in the smallest of the species. By fractionating RNA from Uukuniemi virus (a member
of the family Bunyaviridae)-infected cells in sucrose gradients, Ulmanen et al. (26) detected
four virus-specific RNAs, two of which directed
the synthesis of virus-specific polypeptides in
vitro. The mRNA species that cosedimented
with the M RNA segment directed the synthesis
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of a 11 OK-molecular-weight protein (found to be
the precursor to G1 and G2). In addition, a 12S
RNA species directed the synthesis of the N
protein and a 30K nonstructural protein.
This communication reports the identification
of four nonpolyadenylated cRNA species synthesized in Akabane virus-infected cells and the
sensitivity of their synthesis to the protein synthesis inhibitors cycloheximide and puromycin.
MATERIALS AND METHODS

Cells and virus stock. Akabane virus (strain R7947)
was obtained from the Queensland Institute of Medical
Research, Brisbane, Australia, and was cloned by
plaque isolation twice before use. Vero cells were
grown in minimal essential medium containing 5%
fetal calf serum. Virus stocks were usually prepared
by infecting confluent monolayers of Vero cells in
roller bottles at a multiplicity of infection (MOl) of
0.01 PFU per cell. High-titer stocks were prepared by
directly pelleting virus from the clarified culture fluids
and resuspending it in phosphate-buffered saline containing 0.2% bovine serum albumin and 0.001%
DEAE-dextran.
Growth of virus and preparation of vRNA. Subconfluent monolayer cultures of Vero cells in roller bottles
were infected with Akabane virus at an MOl of 0.001
PFU per cell. After 1 h of virus adsorption at r~m
temperature, inocula were removed and replaced With
virus growth medium and incubated at 37"C for about
35 h. Virus was concentrated from clarified supernatant by polyethylene glycol precipitation (22) or by
direct pelleting and purification by centrifugation in
potassium tartrate-glycerol gradients (22). After repelleting the virus, viral genomic RNA (vRNA) was
extracted with sodium dodecyl sulfate (SDS) and
phenol (1).
32P-labeled vRNA was prepared similarly from virus
grown in phosphate-free medium containing 1 mCi of
32Pi per ml. The vRNA segments were resolved by
electrophoresis in a 3% polyacrylamide gel (120 V for
16 h) containing 6 M urea and 90 mM Tris-EDTAborate buffer, pH 8.3. The individual RNA segments
were detected by autoradiography, excised, eluted
from the gel (in 10 mM Tris-hydrochloride, pH 7.5,
1 mM EDTA, 0.5% SDS, 0.5 M NaCI), and precipitated with ethanol.
Preparation of RNA from infected cells. Confluent
monolayers of Vero cells were infected with Akabane
virus at a usual MOl of approximately 7. After 1 h of
virus adsorption at room temperature, inocula were
removed and the monolayer was washed with warm
phosphate-buffered saline and incubated in the presence of Hanks balanced salt solution supplemented
with 15 mM HEPES (N-2-hydroxyethylpiperazine-N'2-ethanesulfonic acid) adjusted to pH 7.4. Actinomycin D (2 j.LgIm!), [5- 3H]uridine (25 to 50 ....Cilm!) ,
cycloheximide (100 ....glml), and puromycin (100 ....glm!)
were added at appropriate times postinfection according to the protocol of each experiment. After completion of the labeling period, cell monolayers were
washed with cold phosphate-buffered saline and dissolved in buffer containing 0.5% SDS, and the RNA
was extracted with phenol and precipitated with etha-
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nol. Polyadenylated and nonpolyadenylated RNAs
were separated by oligodeoxythymidylate [oligo(dT)]cellulose chromatography (1).
RNA-RNA bybridization and electropboresis. Labeled cRNAs from infected cells were hybridized with
an excess of unlabeled vRNA (17). The hybrid molecules thus formed were digested with single strandspecific nuclease SI (1,000 Ulml) at 37"C for 2 h and
the residual double-stranded RNAs (dsRNAs) recovered by ethanol precipitation were analyzed by electrophoresis on a 4% polyacrylamide gel at 40V for 15
to 20 h (17). The gel was processed for fluorography
(8), and the radioactive bands were detected by exposing the dried gel to X-ray film at -70"C (19).
To determine the excess of unlabeled vRNA required by hybridization, fixed amounts of [3H]cRNA
from the virus-infected cells were hybridized with
increasing amounts of unlabeled vRNA. The trichloroacetic acid-precipitable radioactivity in portions of the
hybridized RNAs before and after SI nuclease digestion was determined (Table 1). This analysis indicated
that saturation levels of hybridization were achieved
by using at least 6 ....g of partially purified vRNA.
Sucrose density gradient analysis. Labeled RNAs for
sucrose density gradient analysis were dissolved in
water, denatured by heating at l00"C for 1 min,
immediately chilled, and adjusted to 10 mM Trishydrochloride (pH 7.5)-100 mM NaCl, 1 mM EDTA0.1% SDS. RNA samples were then analyzed by
sedimentation through 15 to 30% (wt/vol) sucrose
density gradients (prepared in the same buffer) in a
Beckman SW41 rotor (25,000 rpm, 16 h, 20GC). Fractions (0.4 ml) were collected from the bottom of the
gradient, and trichloroacetic acid-precipitable radioactivity in portions of each fraction was determined.
Where appropriate, RNAs were recovered from the
gradient by ethanol precipitation of the pooled peak
fractions.
Materials. Cycloheximide, puromycin, and nuclease
SI were obtained from Sigma Chemical Co., oligo(dT)cellulose from Collaborative Research Inc., and [53H]-uridine from the Radiochemical Centre, Amersham, England. Actinomycin D was a gift from Merck
Sharp & Dohme, Australia. [3H]uridine-labeled
dsRNA from Wallal virus was a gift from P. J. Walker,
Queensland Institute of Medical Research, Brisbane,
Australia.

TABLE 1. Determination of the saturating level of
unlabeled vRNA re~uired for hybridization with
[ H]cRNA
Amt <1'&) of unlabeled vRNA
hybridized with [3H)cRNA
from 2 x lQ'l cells

% Radioactivity resistant to
Sl nuclease digestion"

o

32
41
50
67
82

1

2
4

6

8

~

10

82

a Determined by precipitating a portion o~ the. hybridized RNAs before and after SI nuclease digestion.
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Sucrose density gradient analysis of vRNA •
[3H]uridine-Iabeled RNA was extracted from
purified virus, and the denatured products were
analyzed by sedimentation in an SDS-containing
sucrose density gradient. A profile of the acidprecipitable radioactivity in the gradient fractions revealed three discrete peaks (Fig. la)
representing RNA species with sedimentation
coefficients of 31, 26, and 13 for the L, M, and S
RNAs, respectively. Molecular weights of 2.15
x 106 , 1.5 X 106 and 0.48 x 106 for these three
RNA species were calculated. The singlestranded nature of the RNA was shown by its
sensitivity to prior digestion with pancreatic
RNase (Fig. la). These data confirmed that
Akabane virus RNA shows the characteristic
properties of RNA from a member of the Bunyaviridae.
Identification of cRNA species in infected cells.
RNA species synthesized in mock-infected or
Akabane virus-infected cells were labeled with
eHluridine from 2 to 8 h postinfection (pj.) in
the presence of actinomycin D. Total RNA was
extracted and analyzed by density centrifugation
in SDS-containing sucrose density gradients
(Fig. Ib). Incorporation of radioactivity into
mock-infected cell RNA was considerably less
than into infected cell RNA and was concentrated at the top of the gradient. Two of the major
peaks of radioactivity in the infected cell RNA
sample corresponded with the sedimentation
positions of the M and S vRNA segments (Fig.
la), whereas a shoulder of radioactive material
(fractions 6 to 10) corresponded to the sedimentation position of the L vRNA segment.
To demonstrate the virus-specific and complementary nature of the RNA synthesis, we hybridized [3H]uridine-labeled RNAs from either
mock- or virus-infected cells with unlabeled
vRNA. Preliminary experiments had shown that
saturation levels of hybridization were achieved
in standardized experiments using approximately 7 ....g of crude vRNA extracted from partially
purified virus. After removal of unhybridized

TOP

FIG. 1. (a) Sucrose density gradient centrifugation
of RNA from purified Akabane virus. lH-labeled RNA
from purified virus was denatured and sedimented
through a 15 to 30% SDS-sucrose density gradient as
described in the text. Fractions (0.4 ml) were collected, and trichloroacetic acid-precipitable radioactivity
in each fraction was determined. Symbols: .0, RNA
from purified virus; e, RNA from purified virus
digested with pancreatic RNase (20 ....g/ml in 10 mM
Tris-hydrochloride [pH 7.5], 0.3 M NaCI at 37°C for 30
min). Arrows indicate the sedimentation position of
lH-labeled 35S poliovirus RNA and 28S and 18S

rRNAs. (b) Analysis of RNA from Akabane virusinfected or mock-infected cells. The virus-infected or
mock-infected cells were labeled with [lHluridine
from 2 to 8 h p.i. in the presence of 2 ....g of actinomycin
D per ml (added at 0 h p.i.). Total labeled RNA was
extracted from each culture and analyzed by centrifugation on 15 to 30% SDS-sucrose density gradients.
Fractions (0.4 ml) were collected and the trichloroacetic acid-precipitable radioactivity in portions of each
fraction was determined. Symbols: 0, RNA from the
virus-infected cells; e, RNA from mock-infected
cells.
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FIG. 2. Polyacrylamide gel electrophoresis of virus-specific dsRNA hybrids. (a) Total RNA from mockinfected (lane A) or virus-infected (lanes Band
B and C) cells labeled with [3Hluridine
[3H]uridine at 2 to 8 h p.i. were either
hybridized with unlabeled vRNAs (lanes A and B) or self-annealed (lane C), digested with nuclease S1,
Si, and
analyzed by electrophoresis on a 4% polyacrylamide gel as described in the text. Lane D represents the dsRNAs
produced by hybridization of [3Hluridine-labeled
[3H]uridine-labeled vRNAs with unlabeled RNAs from virus-infected cells at 8 h
p.i. After electrophoresis, the radioactive bands were detected by ftuorography.
fluorography. Arrowheads with arbitrary
numbers represent the four virus-specific dsRNA hybrids. (b) Infected or mock-infected cultures were incubated
in presence of actinomycin D at 0 h p.i. and labeled with [3Hluridine
[3H]uridine for 2-h periods at various times starting at 0
above..
h p.i. The RNAs were then hybridized with unlabeled vRNAs, and the duplexes formed were analyzed as above
Duplexes in lanes B to G were derived from infected cells labeled at 0,2,4,6,8,
respectively.. Lane
0, 2, 4, 6, 8, and 10 h p.i., respectively
A corresponds to a mock-infected culture labeled similarly.

RNAs by digestion with Sl
Si nuclease, the double-stranded hybrid molecules were resolved by
polyacrylamide gel electrophoresis (Fig. 2a).
Four radioactive bands representing four
dsRNA hybrids (arbitrarily numbered 1 to 4)
were detected in extracts from virus-infected
cells (lane B) but not from mock-infected cells
(lane A)
A).. When a portion of 3H-labeled RNA
from infected cells was self-annealed, digested
with nuclease S1,
Si, and analyzed similarly, the
same four hybrid RNAs were detected (Fig. 2a,
lane C). This result indicated that RNA of both
polarities was synthesized in infected cells during the period 2 to 8 hpj.
h p.i. To confirm that
hybridization to vRNA was occurring in these

experiments, the reverse procedure of hybridizing [3H]uridine-Iabeled
[3H]uridine-labeled vRNA to unlabeled RNA
from infected cells was done (Fig. 2a, lane D).
Four hybrid RNAs with the same electrophoretic mobilities as seen in lane B were detected. All
four eRN
A species in infected cells were shown
cRNA
to be cytoplasmic rather than nuclear in their
location (data not shown).
Coding origin of cRNA species. The results in
of four cRNA
Fig. 2 demonstrated the presence offour
species in the virus-infected cells. To identify
the coding origins of these cRNAs, vRNA uniformly labeled with 32p was prepared, and the
three single-stranded RNA segments were resolved by polyacrylamide gel electrophoresis (as
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FIG. 3. Coding origin of the induced cRNA
(cRNA spe32PlvRNA (total or
cies. Uniformly labeled [(32P]vRNA
individual
oir individual
unlabeled
segments) was
of unlabeled
was hybridized with an excess of
cRNAs from virus-infected cells and analyzed
by
ar
by
electrophoresis as in Fig. 2 and detected
detecte by autototal
radiography
radiography.. Hybrids were produced with total
32 PlvRNA (lane A), L RNA segment (lane
[[32P]vRNA
(llane B), M
RNA segment (lane C), and S RNA segment
D)..
segmelnt (lane D)

dalyzed

withd

described above)
above).. The recovered individual
RNA segments were each hybridized with an
excess
excess of unlabeled cRNA from infected cells,
digested with S1
Si nuclease
nuclease,, and analyzed by
polyacrylamide gel electrophoresis. The unfrac32p]vRNA upon
tionated [[32P]vRNA
upon hybridization produced
the four typical dsRNA hybrids (Fig. 3, lane A).
The L RNA upon
upon hybridization produced hybrid 1, whereas the M RNA gave rise to hybrid 2
(lanes Band
B and C, respectively). In contrast, the S
RNA yielded both hybrid 3 and hybrid 4 (lane D)
upon
upon hybridization.
Kinetics of cRNA synthesis. To follow the
kinetics of synthesis of cRNA species after
infection, we infected parallel cultures at an
MOl
MOI of 7 PFU per
per cell and incubated in the
presence
ml.
,ug of actinomycin D per mt.
presence of 2 ILg

was added for 2-h periods at various
[3H]uridine was
times from 0 to 10 h p.i. Labeled RNAs were
extracted, hybridized with an excess of vRNA,
extracted,
and analyzed (Fig. 2b) as described above (Fig.
2a).
of the
the virus-specific
virus-specific RNAs
RNAs
2a). Two
Two of

were dede-

were

as early as 22 h p.i. (lane B) by this
tected as
procedure. By 4 h p.i. all four duplex RNAs
were readily detected, and RNA synthesis
were
reached a peak at 4 to 6 h p.i. After 8 h, the
synthesis of the largest hybrid species fell below
detectable levels, whereas the synthesis of the
other three hybrids continued but in reduced
amounts. These data indicate that temporal control of the synthesis of cRNA species of Akabane virus occurs during infection.
infection. In similar
experimental conditions, the time of maximal
virus-specific protein synthesis coincided with
the time of maximal cRNA synthesis (data not
shown).
shown).
The molecular weights of the RNA hybrid
species were determined by comparison with the
known values of the dsRNA of Wallal orbivirus
(16). Table 22 shows the molecular weights of
these hybrids, their corresponding single-stranded components, and the calculated coding potential, after translation, of possible proteins.
Capacity of cRNAs to bind to oligo(dT)-cellulose. To determine whether the cRNA species in
Akabane virus-infected cells could be separated
into populations of polyadenylated or nonpolyadenylated molecules, fractionation was attempted by oligo(dT)-cellulose chromatography
chromatography..
eH]uridine-labeled
[3H]uridine-labeled RNA was extracted from
times after
after
or late
late times
at either early or
infected cells at
infection, and the polyadenylated RNA species
were separated from the nonpolyadenylated
,ug/ml) was inRNA. When actinomycin D (2 lLg/ml)
cluded during the labeling period (4 to 8 h p.i.),
less
than 4%
4% of
of the
the acid-precipitable
acid-precipitable radioactivless than
ity was found to bind specifically to and elute
from oligo(dT)-cellulose. In contrast, a similar

TABLE 2. Molecular weights of Akabane virusspecific cRNAs and their coding potentials
Mol WI
wt (XI06)
(x 106)
Hybrid RNA
species

dsRNA

1
2
3
4

3.8
2.76
0.25
0.21

dsRNA0
Q

Corresponding
Corresponding
single-stranded
single-stranded
RNA

Approximate
Approximate
coding
potential

( XIOl)b
RNA(x0)

1.9

1.38
0.125
0.105

210
153
14
14
12

a
Molecular weights of the dsRNAs were calculated
Wallal orbiby using the double-stranded RNAs of Waiial
virus (16) as molecular weight standards.
bb The coding potential of each of the cRNA species
was calculated as one-ninth of their respective molecular weights.
Q
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fractionation of host cell RNA labeled in the
absence of actinomycin showed that 35% of the
incorporated radioactivity was in a polyadenylated form.
Evidence that virus specific cRNAs were present in the fraction that failed to bind to oligo(dT)-cellulose was provided by hybridization
experiments. Polyadenylated and nonpolyadenylated RNAs from infected cells labeled either
early (0 to 4 h p.i.) or late (4 to 8 h p.i.) were
isolated and hybridized with an excess of vRNA
and analyzed as described above. The virusspecific dsRNA hybrids could only be seen in
the lanes containing products derived from nonpolyadenylated RNAs (Fig. 4, lanes A and C).
Hybrid RNA 1I species could be detected early
after infection by longer exposure of the gel to
X-ray film (lane A), but was clearly present
when labeling was done at the time of maximal
RNA synthesis (lane C). The broad band of
radioactivity seen in the lower part of the gels is
a residual host component as actinomycin D was
not included in this experiment. Preliminary
experiments to test the sensitivity of this f1uofluorography method showed that if virus-specific
radioactivity in the polyadenylated samples had
exceeded 2% of that in the nonpolyadenylated
samples then discrete bands would have been
visible in lanes BBand
and D (Fig. 4). Additional
experiments were done to try to detect virusspecific polyadenylated RNA species in Akabane virus-infected cells by analyses in sucrose
density gradients. When the small amount of
polyade",lated RNA that could be isolated was
polyadentylated
analyzed as described in Fig. lb, no radioactive
peaks corresponding to viral RNAs could be
detected (data not shown).
shown). Thus, by either method of detection, no virus-specific polyadenylated RNA species could be found in Akabane
virus-infected cells.
Virus-specific RNA synthesis in the presence of
or
protein synthesis inhibitors. Results of self-anRNAs from infected cells (Fig.
ofRNAs
(Fig. 2a) and
nealing of
the partial resistance of such intracellular RNAs
to digestion with pancreatic RNase (data not
shown) indicated that RNAs of both polarities
were being synthesized even at early times after
infection. It has been well established (2, 20, 23)
with other negative-strand viruses that inhibitors
of protein synthesis prevent the translation of
mRNA synthesized early in infection and so
restrict viral RNA synthesis to that of only the
primary type. In such conditions, only cRNAs
that correspond to viral mRNAs are produced.
The classical protein synthesis inhibitors cycloheximide and puromycin were used to treat
Akabane virus-infected
virus-infected cells from the time of
infection.
infection. [3H]uridine
eH]uridine was added at 22 hh p.i.
p.i. for a
further 4 h. After extraction
extraction and denaturation,
denaturation,
the labeled RNAs
RN As were analyzed by sucrose
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FIG. 4. Electrophoretic analysis of dsRNAs
fonned by hybridization of polyadenylated or nonformed
polyadenylated RNAs from the virus-infected cells.
[3Hluridine-labeled RNA from the virus-infected cells
[3H]uridine-labeled
at 0 to 4 h (lanes A and B) or 4 to 8 h (lanes C and D)
were fractionated into polyadenylated and nonpolyadenylated RNAs by oligo(dT)-cellulose chromatography and hybridized to vRNA and analyzed as described in the legend to Fig. 2. Lanes A and C contain
RNAs ,
duplexes derived from nonpolyadenylated RNAs,
whereas lanes BB and D contain duplexes from polyadenylated fractions.

5). The gradensity gradient centrifugation (Fig. 5).
dients containing mock-infected cell RNAs or
infected cell RNAs (in the absence of cycloheximide or puromycin) produced profiles similar to
that seen in Fig. lb. However, the RNA profiles
from cultures treated with either of the drugs
failed to reveal any radioactive peaks corresponding to the sedimentation positions of the L
M vRNA
vRN A segments. Minor peaks of radioacand M
tivity were seen in these gradients, correspondofthe
ing to the sedimentation position of
the S vRNA
segment, which was also the region to which
segment,
some labeled host RNAs sedimented (see the
mock-infected profile, Fig. 5). These results
mock-infected
indicated that RNA synthesis in the presence of
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FIG. 5. Sucrose density gradient analysis of RNA
from virus-infected or mock-infected cells in the presence of cycloheximide or puromycin. Infected or
mock-infected cultures were incubated in the presence
of actinomycin D and either cycloheximide (100 j.Lg!ml)
or puromycin (100 j.Lg/ml) from the time of infection.
RNAs labeled with [3Hluridine from 2 to 6 hpj. were
extracted and analyzed by centrifugation on 15 to 30%
SDS-sucrose density gradients as described in the
legend to Fig. 1. RNA from mock-infected cells (e)
and RNA from Akabane virus-infected cells either
directly (0) or in the presence of cycloheximide (0) or
puromycin (_).

either of these inhibitors was below detectable
levels in this analysis. Even if the MOl in such
experiments was increased to 50 PFU per cell,
no RNA synthesis was detectable in cells in
which protein synthesis had been stopped by
these inhibitors (see below).
To determine whether the radiolabeled RNA
species in Fig. 5 were virus specific, the RNAs
in four regions of the gradients (numbered I, II,
III, and IV) were recovered by ethanol precipitation and hybridized with an excess of unlabeled vRNA. When the resulting dsRNAs after
S1 nuclease digestion were analyzed by polyacrylamide gel electrophoresis, virus-specific
RNAs could be demonstrated only in fractions I
to III of the gradient containing RNA from the
control infected cells (data not shown). No virus-specific products were detected in gradients
containing RNA from either cycloheximide- or

VIROL.

puromycin-treated cells (data not shown), which
confirmed that primary RNA transcription in
such treated cells was below detectable levels.
Since the inhibitory effects of puromycin and
cycloheximide on protein synthesis are fully
reversible, it was of interest to determine whether RNA synthesis in treated infected cells would
recommence if the drugs were removed. To
make the detection of any primary transcription
in such cells more likely, an MOl of 50 PFU per
cell was used. Cycloheximide and puromycin
were added to four cultures at the time of
infection. At 1.75 h p.i., the drugs were thoroughly washed from two of the cultures over a
period of 10 min. All four cultures (together with
an untreated control culture) were labeled with
CH]uridine from 2 to 6 h p.i. The labeled RNA
from each culture was hybridized with vRNA
and analyzed as described above (Fig. 6a). No
dsRNAs were seen when cycloheximide was
retained in the culture (lane B), but a faint band
corresponding to the fourth viral hybrid RNA
could be seen in the corresponding puromycintreated sample (lane D). When the inhibitors
were washed from the cultures, cRNA synthesis
was restored as shown by the presence of the
typical pattern offour dsRNAs in lanes C and E.
However, the inhibitory effect of cycloheximide
could not be completely reversed within the
labeling period used as judged by a comparison
of the intensities of the radioactive bands (lanes
A and C).
Since in the presence of cycloheximide and
puromycin primary transcription was selow detectable levels, an experiment was done to show
their effects on secondary (amplified) RNA transcription when synthetic rates are much higher.
Five cell cultures were infected (at the usual
MOl of 7 PFU per cell) and incubated for 4 h to
allow RNA synthesis to reach its maximal rate.
Cycloheximide and puromycin were added to
two cultures each and then washed from two
cultures at 5.75 h p.i. [3H]uridine was added for
a further 4 h before preparing and analyzing
samples as described for Fig. 6a.
Results observed (Fig. 6b) indicated that both
cycloheximide and puromycin had a dramatic
inhibitory effect on secondary RNA transcription also (lanes B and D) and that this inhibition
could be readily reversed by washing the drugs
from the cell cultures (lanes C and E). However,
the effect of puromycin on secondary transcription was not complete, as a faint band of radioactivity corresponding to hybrid RNA 4 can be
seen in lane D, Fig. 6b. The sensitivity of the
ftuorography procedure used could just detect
bands containing 2% of the radioactivity of
control bands (lane A), and so an estimate ofthe
effect of puromycin on RNA synthesis in this
experiment is that it is at least 90% complete.
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FIG. 6. Effect of cycloheximide and puromycin on RNA synthesis in virus-infected cells. (a) Cultures
infected with Akabane virus at a multiplicity of infection of 50 PFU per cell were treated with either
cycloheximide (100 fLglml)
,ug/ml) or puromycin (100 fLglml)
,ug/ml) at 0 h p.i. At 1.75 h p.i., drugs from one set of cultures were
washed out and the cells were labeled with PH]uridine
[3H]uridine from 2 to 6 h p.i. The RNAs were extracted, hybridized
with unlabeled vRNAs, and analyzed by polyacrylamide gel electrophoresis
electrophoresis.. Duplexes were derived from
B and D, respectively), or when
infected cells (lane A), in the presence of cycloheximide or puromycin (lanes Band
cycloheximide and puromycin were washed out (lanes C and E, respectively).
respectively). (b) Similar analysis of the
duplexes when cell cultures were infected at an MOl
MOI of 7 PFU per cell were treated with cycloheximide or
puromycin at 4 h p.i., and the drugs were washed out at 5.75 h p.i. RNA was labeled with PH]uridine
[3H]uridine from 6 to 10
h p.i. Duplexes were from infected cells (lane A) in the presence of cycloheximide or puromycin (lanes 8B and D,
respectively).
respectively) or when cycloheximide and puromycin were washed out (lanes C and E
E,, respectively).
DISCUSSION

Analysis of the RNA contained in Akabane
virus particles indicated that it was typical of
that found for other bunyaviruses in that the
genome RNA was single stranded and in three
segments, although the measured sizes of these
segments were slightly smaller than those found
for other members of the family (5). However,
Akabane virus was found to differ from the
general properties shown by negative-strand viruses in that no polyadenylated cRNA species
could be detected in infected cells, and established secondary RNA transcription was sensitive to the action of inhibitors of protein synthesis. In addition, four species of cRNA were
detected in Akabane virus-infected cells, which
differs from the three found previously for snowshoe hare bunyavirus (9).
The synthesis of eH]uridine-labeled
[3H]uridine-labeled cRNA in
Akabane virus-infected cells was followed by

hybridization with unlabeled vRNA and analysis
of the 3H-labeled hybrid species so formed by
gel electrophoresis.
electrophoresis. This was necessary because
the usual experimental procedures used with
negative-strand viruses to analyze only primary
RNA transcripts resulted in undetectable levels
of [3H]uridine incorporation. Kinetic studies of
cRNA synthesis at various times after infection
at an MOI
MOl of 7 PFU per cell (Fig. 2b) showed
that detectable synthesis was established as early as 2 hhpj.
p.i. At this time, only RNA hybrids 2
and 4 were visible (Fig. 2b, lane B). Synthesis of
cRNAs increased as the infection proceeded,
cRNA~
reaching a maximal rate at 4 to 6 hhpj.
p.i. At this
time, all four hybrid species representing the
four cRNA species were detected readily (lane
D). The synthesis of the cRNA species leading
to the formation of hybrid 11 was the first to
decrease to below detectable levels (lane E),
whereas synthesis of the cRNA species leading
to the formation of hybrid 33 persisted along with
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hybrids 2 and 4 until after 10 hpj. These results
show that although all four cRNA species
reached their time of maximal synthesis together
(4 to 6 hpj.), there was limited temporal control
over the synthesis of individual cRNA species.
To confirm that the four cRNA species being
labeled in these experiments truly represented
viral cRNA species, the alternative experiment
in which [3H]uridine-labeled vRNA was hybridized with unlabeled infected cell RNAs was
done and analyzed similarly. Again four species
of double-stranded hybrid molecules that
showed the same electrophoretic mobilities as
those in the converse experiment (Fig. 2a, lanes
B and D) were found. This result contrasted with
the results of Cash et al. (9) who found only
three such hybrid species in analyses of snowshoe hare virus-infected cells. Although the single-strand-specific SI nuclease was used routinely in our experiments to digest unhybridized
(single-stranded) molecules, the same four hybrid RNA species could be produced if the
RNases T t or T2 were used instead for the
digestion step (data not shown).
Molecular weights of the hybrid dsRNAs and
the corresponding cRNAs were determined by
comparison with the genome RNAs of the described orbivirus, Wallal (16). The derived sizes
ofthe cRNA species (Table 1) were smaller than
the values measured for the vRNAs, indicating
that none represented full-length transcripts of
the genome RNAs. The coding potentials of the
cRNAs (calculated as one-ninth of the molecular
weight of the cRNA) were found to be approximately 210 x 103, 153 X 103, or 14 x 103 daltons
respectively for the L, M, or S transcripts (Table
1). Either of the cRNAs represented in hybrid
species 1 and 2 appear to have sufficient codin§
information for either the L protein (121 x 10
daltons) or the G t and G2 proteins together (140
x 103 daltons, total). In contrast, the cRNAs
present in hybrid species 3 and 4 do not appear
to be large enough to code for either the L or G t
plus G2 proteins. Within the approximations
used for calculating the coding potentials of
these cRNAs, it seems possible that one of
cRNA species present in either hybrid 3 or 4
codes for the N protein. This conclusion has
been supported by preliminary in vitro translation of the RNA species in region III, Fig. 5,
which has resulted in the translation of only the
polypeptide corresponding to the N protein (unpublished results). Hybrid RNA species 3 and 4
are similar in size and may have overlapping
sequences since hybridization shows that they
are both derived from segment S of viral RNA
(Fig. 3). If so, this information is consistent with
the report of Bishop and co-workers (6) that the
S segments of bunyaviruses have sequences
that allow for the potential expression of two
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gene products by using overlapping reading
frames. Additional non structural proteins found
in various bunyavirus-infected cells (12, 25, 26),
including Akabane virus (21), could conceivably
be translated from the remaining cRNA species.
None of the RNAs synthesized in Akabane
virus-infected cells was found to be polyadenylated, based on their inability to bind specifically
to oligo(dT)-cellulose. The RNA synthesized at
early times after infection and presumably containing the products of primary transcription
failed to bind to oligo(dT)-cellulose in amounts
sufficient to analyze as being virus specific (Fig.
4). In contrast, RNA from the fraction which
failed to bind to oligo(dT)-cellulose could readily
be demonstrated to contain virus-specific molecules. Similar results were obtained if RNA
synthesized at later times (undoubtedly including the products of secondary transcription) was
used for the analysis (Fig. 4). If the MOl in
experiments of this type was increased to approximately 50 PFU per cell to increase the
probability of detecting primary RNA transcripts, the results were unchanged (data not
shown). It could be argued that the level of
polyadenylated RNA synthesis was too low to
detect in these experiments. However, the data
in Fig. 4 combined with measurements of the
sensitivity of the fluorography detection procedure indicate that the synthesis of virus-specific
nonpolyadenylated RNA was at least 30 times
higher than that of polyadenylated RNA in Akabane virus-infected cells. Such a situation is
unique among the negative-strand viruses in
general, but is consistent with work reported
previously for another bunyavirus, Uukuniemi
virus (26). However, it conflicts with the results
of Cash et al. (9), who were able to show that
both polyadenylated and nonpolyadenylated
RNA fractions from snowshoe hare virus-infected cells could be translated in vitro to produce
the nucleocapsid protein N. Preliminary studies
in our laboratory with in vitro translation systems suggest mRNA activity is associated only
with nonpolyadenylated RNA in Akabane virusinfected cells, thus supporting our contention
that in this system no polyadenylated RNAs can
be detected.
It is accepted that the first new synthetic
event in cells infected with a negative-strand
virus is the production of mRNA by the virusassociated RNA polymerase. This primary transcription is independent of protein synthesis.
However, the change to secondary (amplified)
transcription is dependent on the expression of
viral proteins, and this transition can be prevented by the use of inhibitors of protein synthesis
(10, 11, 28). Thus, cycloheximide and puromycin were used to treat Akabane virus-infected
cells from the time of infection to examine
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primary RNA transcription products. When analyzed either by sedimentation in SDS-containing
sucrose density gradients or by hybridization
plus gel electrophoresis, no virus-specific RNA
products could be detected (Fig. 5 and 6). Similar results were obtained if the inhibitors were
not added until the time of maximal RNA synthesis, when secondary transcription was undoubtedly occurring. This was a surprising result as secondary transcription with other
negative-strand viruses has not been reported to
be dependent upon continuing protein synthesis
(23, 24). Similar effects were observed if an
alternate protein synthesis inhibitor, emetine,
was used (data not shown). Studies on the
primary transcription of bunyaviruses in the
presence of cycloheximide or puromycin have
been reported previously. In snowshoe hare
virus-infected cells at a high MOl, low levels of
RNA synthesis could be detected by hybridization in the presence of cycloheximide but not in
the presence of puromycin (27). Similar results
also were obtained by using mutants ofthis virus
(27). RNA synthesis in Bunyamwera virus-infected cells in the presence of cycloheximide has
been examined (18) and again [3H]uridine incorporation levels were only marginally above
background levels, and the products were not
shown to be complementary to vRNA. Thus, in
both of these reports and the results presented in
this communication, primary RNA transcription
by bunyaviruses in the absence of protein synthesis has not been demonstrated conclusively.
The synthesis of protein and RNA in Akabane
virus-infected cells appeared to be linked. Since
the inhibitory effects of cycloheximide and puromycin on protein synthesis can be readily reversed by the washing of treated cells, it was of
interest to see whether secondary RNA transcription was affected similarly. The results in
Fig. 6a and b show that secondary transcription
can be readily established after the removal of
either inhibitor (Fig. 6a) and can recommence
and approach former synthetic rates if interrupted by the action of these drugs (Fig. 6b). Although it is not known whether the effects of
cycloheximide and puromycin on Akabane viral
RNA synthesis are direct or indirect, it seems
that the latter alternative is possible because of
the correspondence between the effects on protein and RNA synthesis and the reversible nature of each (Fig. 6b). The conclusion follows
that secondary RNA transcription (and perhaps
primary transcription as well) in Akabane virusinfected cells is dependent on continuing protein
synthesis.
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